Evaluation of Structural and Functional Outcomes After the Application of an Initial Single Dose of Faricimab.

Ariza-Torrado IP, Groman-Lupa S, Martínez-Córdoba CJ, Monje-Tobar P.

DOI: 10.1177/24741264261451498
Published: 2026-06-16
Container: J Vitreoretin Dis
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/24741264261451498,
  title = {Evaluation of Structural and Functional Outcomes After the Application of an Initial Single Dose of Faricimab.},
  author = {Ariza-Torrado IP and  Groman-Lupa S and  Martínez-Córdoba CJ and  Monje-Tobar P.},
  year = {2026},
  journal = {J Vitreoretin Dis},
  doi = {10.1177/24741264261451498},
  url = {https://doi.org/10.1177/24741264261451498}
}

RIS

TY  - JOUR
TI  - Evaluation of Structural and Functional Outcomes After the Application of an Initial Single Dose of Faricimab.
AU  - Ariza-Torrado IP
AU  -  Groman-Lupa S
AU  -  Martínez-Córdoba CJ
AU  -  Monje-Tobar P.
PY  - 2026
JO  - J Vitreoretin Dis
DO  - 10.1177/24741264261451498
UR  - https://doi.org/10.1177/24741264261451498
ER  -

APA

IP, A., S, G., CJ, M., & P., M. (2026). Evaluation of Structural and Functional Outcomes After the Application of an Initial Single Dose of Faricimab.. J Vitreoretin Dis. https://doi.org/10.1177/24741264261451498

Source records

europe-pmc · retrieved 2026-09-25T10:29:32.023Z